Evaluation of the Effectiveness of Risk Minimisation Measures: A Survey among Health Care Professionals to Assess their Knowledge on Dosing and Administration of Obizur® (Susoctocog alfa) in 6 European Countries First published 23/05/2019 Last updated 04/08/2022 EU PAS number:EUPAS29813 Study Finalised